Intraocular sarcoidosis: association of clinical characteristics of uveitis with findings from 18F-labelled fluorodeoxyglucose positron emission tomography

Br J Ophthalmol. 2012 Jan;96(1):99-103. doi: 10.1136/bjo.2010.194514. Epub 2011 Apr 3.

Abstract

Aims: To assess specific clinical criteria in patients with uveitis that are related to signs of sarcoidosis on (18)F-labelled fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET).

Methods: Retrospective study of 54 consecutive patients with chronic uveitis for whom a PET scan was done because of suspected sarcoidosis, between July 2004 and December 2009. All the patients underwent a clinical examination, biological tests and a high-resolution CT of the chest.

Results: 17 of the 54 patients (31.5%) presented hypermetabolic foci on (18)F-FDG-PET scan consistent with sarcoidosis. Among them eight patients (14.8%) underwent biopsy showing non-caseating granuloma. At the end of the study, 10 patients (18.5%) were considered as having a presumed sarcoidosis and seven patients (12.9%) as having indeterminate sarcoidosis. The increasing age at the diagnosis of uveitis (p=0.01), the presence of posterior synechiae (p=0.01) and a positive high-resolution CT of the chest (p=0.01) were significantly related to an abnormal PET scan.

Conclusions: Increasing age at the diagnosis of uveitis, the presence of posterior synechiae and the positivity of high-resolution chest CT are associated with (18)F-FDG PET scan signs consistent with sarcoidosis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biopsy
  • Female
  • Fluorodeoxyglucose F18
  • Granuloma / diagnostic imaging
  • Granuloma / pathology
  • Humans
  • Lung Diseases / diagnostic imaging
  • Male
  • Middle Aged
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals
  • Retrospective Studies
  • Sarcoidosis / diagnostic imaging*
  • Sarcoidosis / pathology
  • Tomography, X-Ray Computed
  • Uveitis / diagnostic imaging*
  • Uveitis / pathology
  • Whole Body Imaging / methods
  • Young Adult

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18